Clinical Trial

Use of Gocovri to Improve Disability Due to Radiation Encephalopathy

Name: Use of Gocovri to Improve Disability Due to Radiation Encephalopathy — clinical trial record (NCT07125222)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A study to assess the effect of Gocovri (extended-release amantidine) to improve disability as assessed by the disability rating scale (DRS) and cognition as assessed by the Montreal Cognitive Assessment (MoCA) test in patients with radiation encephalopathy.

Trial Details

NCT Number	NCT07125222
Lead Sponsor	Weill Medical College of Cornell University
Conditions	Encephalopathy, Radiation Effect
Enrollment	24 participants
Start Date	2026-09
Primary Completion	2028-08 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2026-08-03